ERBB2 and breast cancer: Having characterized the performance of the D4 chip and the dual-function imaging capability of the EpiView, we next sought to test the ability of the combined platform—the EpiView-D4—to assess both cytomorphology of FNA preparations and HER2 expression in animal models of human breast cancer (Fig. 4a).